NM_012199.5:c.165C>T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2

The NM_012199.5(AGO1):​c.165C>T​(p.Tyr55Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00251 in 1,614,206 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0019 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 76 hom. )

Consequence

AGO1
NM_012199.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 1.03

Publications

1 publications found
Variant links:
Genes affected
AGO1 (HGNC:3262): (argonaute RISC component 1) This gene encodes a member of the argonaute family of proteins, which associate with small RNAs and have important roles in RNA interference (RNAi) and RNA silencing. This protein binds to microRNAs (miRNAs) or small interfering RNAs (siRNAs) and represses translation of mRNAs that are complementary to them. It is also involved in transcriptional gene silencing (TGS) of promoter regions that are complementary to bound short antigene RNAs (agRNAs), as well as in the degradation of miRNA-bound mRNA targets. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. A recent study showed this gene to be an authentic stop codon readthrough target, and that its mRNA could give rise to an additional C-terminally extended isoform by use of an alternative in-frame translation termination codon. [provided by RefSeq, Nov 2015]
AGO1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 1-35888566-C-T is Benign according to our data. Variant chr1-35888566-C-T is described in ClinVar as Benign. ClinVar VariationId is 787855.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.03 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0019 (290/152314) while in subpopulation SAS AF = 0.0351 (169/4820). AF 95% confidence interval is 0.0307. There are 4 homozygotes in GnomAd4. There are 213 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 290 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012199.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGO1
NM_012199.5
MANE Select
c.165C>Tp.Tyr55Tyr
synonymous
Exon 2 of 19NP_036331.1Q9UL18
AGO1
NM_001317123.2
c.-61C>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 19NP_001304052.1Q5TA58
AGO1
NM_001317122.2
c.165C>Tp.Tyr55Tyr
synonymous
Exon 2 of 19NP_001304051.1A0A6I8PTZ8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGO1
ENST00000373204.6
TSL:1 MANE Select
c.165C>Tp.Tyr55Tyr
synonymous
Exon 2 of 19ENSP00000362300.4Q9UL18
AGO1
ENST00000373206.5
TSL:2
c.-61C>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 19ENSP00000362302.1Q5TA58
AGO1
ENST00000674426.1
c.165C>Tp.Tyr55Tyr
synonymous
Exon 2 of 19ENSP00000501372.1A0A6I8PTZ8

Frequencies

GnomAD3 genomes
AF:
0.00190
AC:
289
AN:
152196
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.0348
Gnomad FIN
AF:
0.00801
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00536
AC:
1347
AN:
251464
AF XY:
0.00675
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000231
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.00725
Gnomad NFE exome
AF:
0.000378
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00257
AC:
3758
AN:
1461892
Hom.:
76
Cov.:
31
AF XY:
0.00347
AC XY:
2523
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.000201
AC:
9
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39700
South Asian (SAS)
AF:
0.0347
AC:
2996
AN:
86258
European-Finnish (FIN)
AF:
0.00730
AC:
390
AN:
53420
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.000149
AC:
166
AN:
1112010
Other (OTH)
AF:
0.00300
AC:
181
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
218
436
655
873
1091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00190
AC:
290
AN:
152314
Hom.:
4
Cov.:
32
AF XY:
0.00286
AC XY:
213
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41564
American (AMR)
AF:
0.000196
AC:
3
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5188
South Asian (SAS)
AF:
0.0351
AC:
169
AN:
4820
European-Finnish (FIN)
AF:
0.00801
AC:
85
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68036
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000393
Hom.:
0
Bravo
AF:
0.000302
Asia WGS
AF:
0.0130
AC:
46
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
AGO1-related disorder (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
13
DANN
Benign
0.53
PhyloP100
1.0
Mutation Taster
=291/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143228790; hg19: chr1-36354167; COSMIC: COSV64596491; COSMIC: COSV64596491; API